Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Pacific Edge named Top Bioscience Company in 2014

Pacific Edge named Top Bioscience Company in 2014


Pacific Edge has been named NZBIO’s top bioscience company for 2014. Pacific Edge was specifically recognised for building the profile and credibility of biotechnology and biotechnology companies in New Zealand.

The announcement of the industry accolade this week is further recognition for the Dunedin based cancer diagnostic company and comes a few months after taking the Supreme Award at the NZ Innovation Council Awards.

Pacific Edge Chief Executive Office David Darling says the Company is delighted to receive the recognition for the advances being made to the clinical capability for the detection and management of cancers. The company’s Urine Sampling System is becoming a core element of the advances in clinical utility, which can be used by the patient in-home to take a sample.

“It is rare in the biotechnology sector to have a company with the capability and resources to go from discovery science all the way through clinical trials and product development to finally making a commercial product as Pacific Edge has done with Cxbladder – our molecular diagnostic test for bladder cancer.”

Cxbladder is a non-invasive test with the Company’s easy to use Urine Sampling System becoming a core element of the advances in clinical utility, which allows patients can use at home. The sample is analysed in one of Pacific Edge’s laboratories for the tell-tale molecular markers that will provide the urologist with information on the probability of the patient having bladder cancer, or not.

Cxbladder is now available commercially in the United States through the company’s own CLIA and CAP regulated laboratory in Hershey, Pennsylvania. In the later part of 2013 the company signed three large, preferred national provider networks. These provider networks provide patients access to healthcare services and technology by contracting with providers and payers on a national basis. These three agreements signed with FedMed, ACPN and Stratose give millions of Americans access to Cxbladder and its positive benefits as a quick, cost effective, non-invasive and highly accurate cancer detection test that is particularly appealing to US healthcare professionals, patients, and insurers.

The custom built, commercial laboratory for Pacific Edge’s US subsidiary PEDUSA was completed in September 2012 to process Cxbladder samples, was certified in 2013 by CLIA and more recently by CAP, to enable the laboratory to offer Cxbladder as a Laboratory Developed Test (LDT) to clinicians and physicians.

Ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Half Empty: Fonterra's 2017 Opening Forecast Below Expectations

Fonterra Cooperative Group raised its forecast farmgate milk payout for next season by less than expected as the world's largest dairy exporter predicts lower prices will crimp production and supply will pick up. The New Zealand dollar fell. More>>

ALSO:

Pest Control: Mouse Blitz Team Leaves For Antipodes

The Million Dollar Mouse project to rid Antipodes Island of mice is underway with the departure of a rodent eradication team to the remote nature reserve and World Heritage Area. More>>

Gongs Got: Canon Media Awards & NZ Radio Awards Happen

Radio NZ: RNZ website The Wireless, which is co-funded by NZ On Air, was named best website, while Toby Manhire and Toby Morris won the best opinion general writing section for their weekly column on rnz.co.nz and Tess McClure won the best junior feature writer section. More>>

ALSO:

Pre-Budget: Debt Focus Risks Losing Opportunity To Stoke Economy

The Treasury is likely to upgrade its forecasts for economic growth in Budget 2016 next week but Finance Minister Bill English has already signalled that more of his focus is on debt repayment than on fiscal stimulus or tax cuts... More>>

ALSO:

Fulton Hogan's Heroes: Managing Director Nick Miller Resigns

Fulton Hogan managing director Nick Miller will leave the privately owned construction company after seven years in charge. The Dunedin-based company has kicked off a search for a replacement, and Miller will stay on at the helm until March next year, or until a successor has been appointed and a transition period completed. More>>

ALSO:

Gordon Campbell: On Electricity, Executions, And Bob Dylan

The Electricity Authority has unveiled the final version of its pricing plan for electricity transmission. This will change the way transmission prices (which comprise about 10% of the average power bill) are computed, and will add hundreds of dollars a year to power bills for many ordinary consumers. More>>

ALSO:

Half Empty: Fonterra NZ, Australia Milk Collection Drops In Season

Fonterra Cooperative Group says milk collection is down in New Zealand and Australia, its two largest markets, in the first 11 months of the season during a period of weak dairy prices. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news